Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary E Landreth

Showing results (21-30 of 120) with videos related to

Pageof 12
Sort By:
The Lancet. Oncology|July 3, 2004
Antineoplastic effects of peroxisome proliferator-activated receptor gamma agonistsChristian Grommes, Gary E Landreth, Michael T Heneka
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|November 19, 2014
The evolving biology of microglia in Alzheimer's diseaseTarja M Malm, Taylor R Jay, Gary E Landreth
Hippocampus|August 24, 2017
Chronic impairment of ERK signaling in glutamatergic neurons of the forebrain does not affect spatial memory retention and LTP in the same manner as acute blockade of the ERK pathwayJoseph Vithayathil, Joanna Pucilowska, David Friel, et al.
Neuron|February 3, 2009
MAP'ing CNS development and cognition: an ERKsome processIvy S Samuels, Sulagna C Saitta, Gary E Landreth
Molecular and Cellular Biology|June 6, 2007
Nerve growth factor stimulates the concentration of TrkA within lipid rafts and extracellular signal-regulated kinase activation through c-Cbl-associated proteinAllison S Limpert, J Colleen Karlo, Gary E Landreth
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 28, 2012
Mechanisms underlying the rapid peroxisome proliferator-activated receptor-γ-mediated amyloid clearance and reversal of cognitive deficits in a murine model of Alzheimer's diseaseShweta Mandrekar-Colucci, J Colleen Karlo, Gary E Landreth
The Journal of Pharmacology and Experimental Therapeutics|January 25, 2005
The nonthiazolidinedione tyrosine-based peroxisome proliferator-activated receptor gamma ligand GW7845 induces apoptosis and limits migration and invasion of rat and human glioma cellsChristian Grommes, Gary E Landreth, Uwe Schlegel, et al.
Journal of Neuroinflammation|February 17, 2018
Nuclear receptor agonist-driven modification of inflammation and amyloid pathology enhances and sustains cognitive improvements in a mouse model of Alzheimer's diseaseBrad T Casali, Erin G Reed-Geaghan, Gary E Landreth
Molecular Neurodegeneration|August 4, 2017
TREM2 in Neurodegenerative DiseasesTaylor R Jay, Victoria E von Saucken, Gary E Landreth
Neurobiology of Disease|September 5, 2020
The effect of amyloid on microglia-neuron interactions before plaque onset occurs independently of TREM2 in a mouse model of Alzheimer's diseaseVictoria E von Saucken, Taylor R Jay, Gary E Landreth
Pageof 12

Showing results (21-30 of 120) with videos related to

Sort By:
Pageof 12
The Lancet. Oncology|July 3, 2004
Antineoplastic effects of peroxisome proliferator-activated receptor gamma agonistsChristian Grommes, Gary E Landreth, Michael T Heneka
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|November 19, 2014
The evolving biology of microglia in Alzheimer's diseaseTarja M Malm, Taylor R Jay, Gary E Landreth
Hippocampus|August 24, 2017
Chronic impairment of ERK signaling in glutamatergic neurons of the forebrain does not affect spatial memory retention and LTP in the same manner as acute blockade of the ERK pathwayJoseph Vithayathil, Joanna Pucilowska, David Friel, et al.
Neuron|February 3, 2009
MAP'ing CNS development and cognition: an ERKsome processIvy S Samuels, Sulagna C Saitta, Gary E Landreth
Molecular and Cellular Biology|June 6, 2007
Nerve growth factor stimulates the concentration of TrkA within lipid rafts and extracellular signal-regulated kinase activation through c-Cbl-associated proteinAllison S Limpert, J Colleen Karlo, Gary E Landreth
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 28, 2012
Mechanisms underlying the rapid peroxisome proliferator-activated receptor-γ-mediated amyloid clearance and reversal of cognitive deficits in a murine model of Alzheimer's diseaseShweta Mandrekar-Colucci, J Colleen Karlo, Gary E Landreth
The Journal of Pharmacology and Experimental Therapeutics|January 25, 2005
The nonthiazolidinedione tyrosine-based peroxisome proliferator-activated receptor gamma ligand GW7845 induces apoptosis and limits migration and invasion of rat and human glioma cellsChristian Grommes, Gary E Landreth, Uwe Schlegel, et al.
Journal of Neuroinflammation|February 17, 2018
Nuclear receptor agonist-driven modification of inflammation and amyloid pathology enhances and sustains cognitive improvements in a mouse model of Alzheimer's diseaseBrad T Casali, Erin G Reed-Geaghan, Gary E Landreth
Molecular Neurodegeneration|August 4, 2017
TREM2 in Neurodegenerative DiseasesTaylor R Jay, Victoria E von Saucken, Gary E Landreth
Neurobiology of Disease|September 5, 2020
The effect of amyloid on microglia-neuron interactions before plaque onset occurs independently of TREM2 in a mouse model of Alzheimer's diseaseVictoria E von Saucken, Taylor R Jay, Gary E Landreth
Pageof 12